Search research articles
Contact Us
Filters
Showing results (281-290 of 451) with videos related to
Page
of 46
Sort By:
Communications Medicine
|
May 12, 2023
Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain
Jeffrey V Lazarus, Marcela Villota-Rivas, Pablo Ryan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 31, 2024
Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral Therapy
Conan Chua, Deeqa Mahamed, Shirin Nkongolo, et al.
Canadian Liver Journal
|
August 22, 2022
The 7th Canadian Symposium on Hepatitis C Virus: "Toward Elimination of HCV: How to Get There"
Michael L Cheng, Mohamed S Abdel-Hakeem, Sophie E Cousineau, et al.
Plos One
|
November 27, 2013
Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection
Jordan J Feld, Jason Grebely, Gail V Matthews, et al.
Pathogens (Basel, Switzerland)
|
June 26, 2024
Differential Gene Expression in the Upper Respiratory Tract following Acute COVID-19 Infection in Ambulatory Patients That Develop Long COVID
Mia J Biondi, Mary Addo, Muhammad Atif Zahoor, et al.
Alimentary Pharmacology & Therapeutics
|
March 28, 2012
Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B
M G Ghany, J J Feld, X Zhao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 3, 2021
Viral hepatitis C cascade of care: A population-level comparison of immigrant and long-term residents
Abdool S Yasseen, Jeffrey C Kwong, Jordan J Feld, et al.
BMC Infectious Diseases
|
June 2, 2016
HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection
François M J Lamoury, Behzad Hajarizadeh, Elizabeth Keoshkerian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment Cessation
Heng Chi, David Wong, Jie Peng, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial
Tarik Asselah, Christophe Hézode, Roula B Qaqish, et al.
Page
of 46
Search research articles
Search
Showing results (281-290 of 451) with videos related to
Sort By:
Page
of 46
Communications Medicine
|
May 12, 2023
Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain
Jeffrey V Lazarus, Marcela Villota-Rivas, Pablo Ryan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 31, 2024
Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral Therapy
Conan Chua, Deeqa Mahamed, Shirin Nkongolo, et al.
Canadian Liver Journal
|
August 22, 2022
The 7th Canadian Symposium on Hepatitis C Virus: "Toward Elimination of HCV: How to Get There"
Michael L Cheng, Mohamed S Abdel-Hakeem, Sophie E Cousineau, et al.
Plos One
|
November 27, 2013
Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection
Jordan J Feld, Jason Grebely, Gail V Matthews, et al.
Pathogens (Basel, Switzerland)
|
June 26, 2024
Differential Gene Expression in the Upper Respiratory Tract following Acute COVID-19 Infection in Ambulatory Patients That Develop Long COVID
Mia J Biondi, Mary Addo, Muhammad Atif Zahoor, et al.
Alimentary Pharmacology & Therapeutics
|
March 28, 2012
Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B
M G Ghany, J J Feld, X Zhao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 3, 2021
Viral hepatitis C cascade of care: A population-level comparison of immigrant and long-term residents
Abdool S Yasseen, Jeffrey C Kwong, Jordan J Feld, et al.
BMC Infectious Diseases
|
June 2, 2016
HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection
François M J Lamoury, Behzad Hajarizadeh, Elizabeth Keoshkerian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment Cessation
Heng Chi, David Wong, Jie Peng, et al.
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial
Tarik Asselah, Christophe Hézode, Roula B Qaqish, et al.
Page
of 46